Optimizing oncolytic virotherapy in cancer treatment
Institute of Cancer Research · AstraZeneca (United States) · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
516
total citations
- FWCI
- 48.40
- Percentile
- 100%
- References
- 215
Citations per year
Authors
5Topics & keywords
Topics
Keywords
- Oncolytic virus
- Immune system
- Virotherapy
- Immunotherapy
- Immunology
- Cancer immunotherapy
- Cancer research
- Immune checkpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.